FDA taps Wiley Chambers as interim Analgesic, Anti-Inflammatory Drugs Division head.
This article was originally published in The Tan Sheet
Executive Summary
FDA ANALGESIC, ANTI-INFLAMMATORY DRUGS DIVISION ACTING DIRECTOR CHAMBERS is taking on the temporary responsibilities of the position while FDA completes a search for a rheumatologist or analgesiologist to take on the permanent division director post. Wiley Chambers, MD, most recently served as a medical officer for ophthalmic drugs in the then-Division of Dermatologic & Ophthalmic Drugs.